Eszopiclone Patent Expiration
Eszopiclone is used for inducing hypnotic or sedative effects in humans. It was first introduced by Waylis Therapeutics Llc
Eszopiclone Patents
Given below is the list of patents protecting Eszopiclone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lunesta |
US6444673 (Pediatric) | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Aug 14, 2014
(Expired) | Waylis Therap |
| Lunesta | US6444673 | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Feb 14, 2014
(Expired) | Waylis Therap |
| Lunesta |
US6864257 (Pediatric) | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Mar 02, 2013
(Expired) | Waylis Therap |
| Lunesta | US6864257 | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Aug 30, 2012
(Expired) | Waylis Therap |
| Lunesta |
US6319926 (Pediatric) | Optically active 5H-pyrrolo[3, 4-B]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Jul 16, 2012
(Expired) | Waylis Therap |
| Lunesta |
US7381724 (Pediatric) | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing same |
Jul 16, 2012
(Expired) | Waylis Therap |
Eszopiclone's Family Patents
Explore Our Curated Drug Screens
Eszopiclone Generic API Manufacturers
Several generic applications have been filed for Eszopiclone. The first generic version for Eszopiclone was by Teva Pharmaceuticals Usa Inc and was approved on May 23, 2011. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Jan 4, 2024.
Given below is the list of companies who have filed for Eszopiclone generic, along with the locations of their manufacturing plants worldwide.
1. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3MG | tablet | Prescription | ORAL | AB | Sep 15, 2016 |
| 1MG | tablet | Prescription | ORAL | AB | Sep 15, 2016 |
| 2MG | tablet | Prescription | ORAL | AB | Sep 15, 2016 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
2. AVIV PHARMA
Aviv Pharma Inc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Aviv Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3MG | tablet | Discontinued | ORAL | N/A | May 8, 2019 |
| 1MG | tablet | Discontinued | ORAL | N/A | May 8, 2019 |
| 2MG | tablet | Discontinued | ORAL | N/A | May 8, 2019 |
3. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Discontinued | ORAL | N/A | Jul 14, 2011 |
| 3MG | tablet | Discontinued | ORAL | N/A | Jul 14, 2011 |
| 2MG | tablet | Discontinued | ORAL | N/A | Jul 14, 2011 |
4. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3MG | tablet | Prescription | ORAL | AB | Apr 15, 2014 |
| 1MG | tablet | Prescription | ORAL | AB | Apr 15, 2014 |
| 2MG | tablet | Prescription | ORAL | AB | Apr 15, 2014 |
5. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Apr 15, 2014 |
| 2MG | tablet | Prescription | ORAL | AB | Apr 15, 2014 |
| 3MG | tablet | Prescription | ORAL | AB | Apr 15, 2014 |
6. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Jan 4, 2024 |
| 3MG | tablet | Prescription | ORAL | AB | Jan 4, 2024 |
| 2MG | tablet | Prescription | ORAL | AB | Jan 4, 2024 |
7. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Discontinued | ORAL | N/A | Apr 15, 2014 |
| 2MG | tablet | Discontinued | ORAL | N/A | Apr 15, 2014 |
| 3MG | tablet | Discontinued | ORAL | N/A | Apr 15, 2014 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
8. IPCA LABS LTD
Ipca Laboratories Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Discontinued | ORAL | N/A | Dec 29, 2023 |
| 1MG | tablet | Discontinued | ORAL | N/A | Dec 29, 2023 |
| 3MG | tablet | Discontinued | ORAL | N/A | Dec 29, 2023 |
9. LUPIN LTD
Lupin Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Sep 13, 2011 |
| 2MG | tablet | Prescription | ORAL | AB | Sep 13, 2011 |
| 3MG | tablet | Prescription | ORAL | AB | Sep 13, 2011 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
10. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Jan 30, 2015 |
| 2MG | tablet | Prescription | ORAL | AB | Jan 30, 2015 |
| 3MG | tablet | Prescription | ORAL | AB | Jan 30, 2015 |
11. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Mar 26, 2013 |
| 2MG | tablet | Prescription | ORAL | AB | Mar 26, 2013 |
| 3MG | tablet | Prescription | ORAL | AB | Mar 26, 2013 |
12. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3MG | tablet | Prescription | ORAL | AB | Jun 10, 2014 |
| 2MG | tablet | Prescription | ORAL | AB | Jun 10, 2014 |
| 1MG | tablet | Prescription | ORAL | AB | Jun 10, 2014 |
13. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Apr 3, 2013 |
| 3MG | tablet | Prescription | ORAL | AB | Apr 3, 2013 |
| 2MG | tablet | Prescription | ORAL | AB | Apr 3, 2013 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
14. TEVA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3MG | tablet | Prescription | ORAL | AB | May 23, 2011 |
| 2MG | tablet | Prescription | ORAL | AB | May 23, 2011 |
| 1MG | tablet | Prescription | ORAL | AB | May 23, 2011 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| India |
| |||||||||
| Canada |
| |||||||||
| Czech Republic |
| |||||||||
| Ireland |
| |||||||||
| Israel |
| |||||||||